SIRT6 and cancer: Taken together, these results indicated that in our mouse model of cancer‐cachexia, skeletal‐muscle specific over‐expression of SIRT6 increased plasma insulin levels, which likely contributed to reduce tumour growth and to preserve muscle mass.